MPT

+ Watchlist + Portfolio

Medical Properties Trust, Inc.

Recurring revenue Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $3.37
52-Week Range: $3.25 – $6.47
Market Cap: $1.95B
P/E (TTM): —
EPS (TTM): -0.05
Dividend Yield: 11.01%

Advanced Metrics

Price/Book: 0.43
PEG Ratio: 1.61
Return on Equity: -0.62%
Return on Assets: 2.77%
Gross Margin: 95.94%
Operating Margin: 57.36%
Profit Margin: -2.73%
Current Ratio: 1.17
Debt/Equity: 2.16
Total Debt: $9.70B
Free Cash Flow: $753.95M
Revenue Growth: 1.90%
Earnings Growth: —
Enterprise Value: $11.26B

MPT Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$1.54B	$871.80M	$995.55M	$972.02M
Cost of Revenue	$45.70M	$41.57M	$27.25M	$36.41M
Gross Profit	$1.50B	$830.23M	$968.29M	$935.61M
Selling, General & Admin	$160.49M	$145.59M	$133.79M	$130.43M
Operating Expenses	$493.47M	$748.95M	$581.45M	$395.83M
Operating Income	$1.00B	$81.28M	$386.85M	$539.77M
EBITDA	$1.35B	$697.41M	$840.60M	$812.59M
Pretax Income	$959.72M	-$686.77M	-$2.36B	-$237.32M
Income Tax	$55.90M	-$130.68M	$44.10M	$38.62M
Net Income	$902.60M	-$556.48M	-$2.41B	-$277.05M
Diluted EPS	1.50	-0.93	-4.02	-0.46
Diluted Shares	598.84M	598.52M	600.25M	600.89M

MPT Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$235.67M	$250.02M	$332.33M	$540.86M
Receivables	$1.18B	$973.66M	$846.28M	$1.09B
Current Assets	$1.72B	$1.40B	$1.31B	$1.82B
Total Assets	$19.66B	$18.30B	$14.29B	$15.00B
Current Liabilities	$1.58B	$1.96B	$845.38M	$1.21B
Long-Term Debt	$9.34B	$8.55B	$8.49B	$9.06B
Total Debt	$10.41B	$10.22B	$8.98B	$9.83B
Total Liabilities	$11.06B	$10.67B	$9.46B	$10.39B
Retained Earnings	$116.28M	-$971.81M	-$3.66B	-$4.14B
Shareholders' Equity	$8.59B	$7.63B	$4.83B	$4.61B
Working Capital	$143.59M	-$567.17M	$468.33M	$609.38M
Net Debt	$10.03B	$9.81B	$8.52B	$9.16B

MPT Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$739.01M	$505.79M	$245.48M	$230.77M
Free Cash Flow	$739.01M	$505.79M	$245.48M	$230.77M
Depreciation & Amortisation	$345.58M	$616.13M	$453.75M	$272.82M
Stock-Based Compensation	$49.42M	$33.25M	$32.98M	$25.75M
Investing Cash Flow	$396.06M	$517.56M	$1.32B	-$264.74M
Financing Cash Flow	-$1.34B	-$1.02B	-$1.48B	$228.08M
Dividends Paid	-$698.53M	-$615.39M	-$321.08M	-$193.26M
Share Repurchases	-$17.94M	$0.00	$0.00	-$23.44M
Net Change in Cash	-$207.46M	$3.02M	$84.44M	$194.11M

MPT Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$223.80M	$240.36M	$237.52M	$270.34M	$252.06M	$259.28M
Cost of Revenue	$7.04M	$10.86M	$8.99M	$9.52M	$9.94M	$11.20M
Gross Profit	$216.76M	$229.50M	$228.53M	$260.82M	$242.13M	$248.08M
Selling, General & Admin	$41.91M	$26.20M	$37.73M	$24.59M	$32.20M	$34.77M
Operating Expenses	$106.48M	$92.91M	$104.73M	$91.71M	$101.92M	$104.22M
Operating Income	$110.28M	$136.58M	$123.80M	$169.11M	$140.20M	$143.86M
EBITDA	$72.65M	$109.68M	$135.29M	$494.96M	$206.96M	$216.68M
Pretax Income	-$108.58M	-$88.27M	-$66.58M	$26.10M	$285.00K	$7.79M
Income Tax	$9.44M	$9.80M	$10.87M	$8.51M	-$32.82M	$10.08M
Net Income	-$118.28M	-$98.36M	-$77.73M	$17.31M	$32.83M	-$2.60M
Diluted EPS	-0.20	-0.16	-0.13	0.03	0.05	-0.01
Diluted Shares	600.59M	600.81M	601.14M	600.97M	597.72M	597.96M

MPT Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$673.48M	$509.83M	$396.58M	$540.86M	$425.00M	$396.56M
Receivables	$909.56M	$1.00B	$1.12B	$1.09B	$1.16B	$1.23B
Current Assets	$1.58B	$1.51B	$1.52B	$1.82B	$1.59B	$1.63B
Total Assets	$14.85B	$15.15B	$14.92B	$15.00B	$14.76B	$14.75B
Current Liabilities	$1.12B	$1.07B	$1.07B	$1.21B	$1.12B	$1.17B
Long-Term Debt	$8.82B	$9.10B	$9.05B	$9.06B	$9.00B	$8.99B
Total Debt	$9.62B	$9.80B	$9.76B	$9.83B	$9.77B	$9.80B
Total Liabilities	$10.09B	$10.32B	$10.26B	$10.39B	$10.22B	$10.25B
Retained Earnings	-$3.83B	-$3.97B	-$4.10B	-$4.14B	-$4.16B	-$4.21B
Shareholders' Equity	$4.76B	$4.83B	$4.66B	$4.61B	$4.54B	$4.50B
Working Capital	$463.13M	$441.60M	$453.32M	$609.38M	$467.69M	$463.24M
Net Debt	$8.79B	$9.14B	$9.22B	$9.16B	$9.24B	$9.31B

MPT Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$384.00K	$51.75M	$18.57M	$160.06M	-$14.26M	$62.44M
Free Cash Flow	$384.00K	$51.75M	$18.57M	$160.06M	-$14.26M	$62.44M
Depreciation & Amortisation	$65.43M	$68.24M	$69.48M	$69.67M	$73.35M	$73.63M
Stock-Based Compensation	$17.66M	$857.00K	$12.34M	-$5.12M	$573.00K	$4.86M
Investing Cash Flow	-$89.42M	-$72.32M	-$95.14M	-$7.87M	-$76.78M	-$82.33M
Financing Cash Flow	$426.32M	-$154.80M	-$34.46M	-$8.98M	-$23.22M	-$8.30M
Dividends Paid	-$48.16M	-$48.38M	-$48.29M	-$48.42M	-$55.35M	-$54.26M
Net Change in Cash	$337.29M	-$175.37M	-$111.02M	$143.21M	-$114.26M	-$28.19M

Market Snapshot

About

Healthcare real estate investment trust owning and leasing hospital facilities worldwide. Business model provides sale-leaseback financing to hospital operators, collecting long-term triple-net lease payments. Portfolio concentrated in acute care hospitals across US and Europe.